1. Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol. 2009; 16(6):420–426. DOI:
10.1097/MOH.0b013e328330990f.
2. Pidala J, Anasetti C, Jim H. Health-related quality of life following haematopoietic cell transplantation: Patient education, evaluation and intervention. Br J Haematol. 2010; 148(3):373–385. DOI:
10.1111/j.1365-2141.2009.07992.x.
3. Cohen MZ, Rozmus CL, Mendoza TR, Padhye NS, Neumann J, Gning I, et al. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage. 2012; 44(2):168–180. DOI:
10.1016/j.jpainsymman.2011.08.011.
4. Andersson I, Ahlberg K, Stockelberg D, Brune M, Persson LO. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning. Cancer Nurs. 2009; 32(4):325–334. DOI:
10.1097/NCC.0b013e31819b5c81.
5. Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P, et al. Health-related quality of life in patients receiving reducedintensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006; 38(2):101–109. DOI:
10.1038/sj.bmt.1705406.
6. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol Blood Marrow Transplant. 2009; 15(10):1143–1238. DOI:
10.1016/j.bbmt.2009.06.019.
7. Grant M, Cooke L, Williams AC, Bhatia S, Popplewell L, Uman G, et al. Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: A comparison of sociodemographic, disease, and treatment characteristics. Support Care Cancer. 2012; 20(11):2697–2704. DOI:
10.1007/s00520-012-1389-8.
8. Braamse AM, Gerrits MM, van Meijel B, Visser O, van Oppen P, Boenink AD, et al. Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant. 2012; 47(6):757–769. DOI:
10.1038/bmt.2011.130.
9. Roy C. The Roy Adaptation Model. 3rd ed. Upper Saddle River, NJ: Pearson;2009.
10. Shin JH. Application of repeated-measures analysis of variance and hierarchical linear model in nursing research. Nurs Res. 2009; 58(3):211–217. DOI:
10.1097/NNR.0b013e318199b5ae.
11. Jung M, Lee H. Predictors of quality of life following HSCT recipients. J Korean Acad Adult Nurs. 2008; 20(2):341–352.
12. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, et al. Assessing symptom distress in cancer patients: The M.D. Anderson symptom inventory. Cancer. 2000; 89(7):1634–1646.
13. Sung HM, Kim JB, Park YN, Bai DS, Lee SH, Ahn HN. A study on the reliability and the validity of Korean version of the Beck Depression Inventory-II (BDI-II). J Korean Soc Biol Ther Psychiatry. 2008; 14(2):201–212.
14. McCorkle R, Benoliel JQ, Donaldson G, Georgiadou F, Moinpour C, Goodell B. A randomized clinical trial of home nursing care for lung cancer patients. Cancer. 1989; 64(6):1375–1382.
15. Kim KH, Kim JH. Korea UCLA loneliness scale. J Stud Guid. 1989; 16:13–30.
16. Barone SH, Roy CL, Frederickson KC. Instruments used in Roy Adaptation Model-based research: Review, critique, and future directions. Nurs Sci Q. 2008; 21(4):353–362. DOI:
10.1177/0894318408323491.
17. Nuamah IF, Cooley ME, Fawcett J, McCorkle R. Testing a theory for health-related quality of life in cancer patients: A structural equation approach. Res Nurs Health. 1999; 22(3):231–242.
18. Ferrans CE, Powers MJ. Quality of life index: Development and psychometric properties. ANS Adv Nurs Sci. 1985; 8(1):15–24.
19. Baker F, Curbow B, Wingard JR. Development of the satisfaction with life domains scale for cancer. J Psychosoc Oncol. 1993; 10(3):75–90. DOI:
10.1300/J077V10N03_05.
20. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation;1996.
21. Russell D, Peplau LA, Cutrona CE. The revised UCLA loneliness scale: Concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980; 39(3):472–480.
22. Baker F, Denniston M, Hann D, Gesme D, Reding DJ, Flynn T, et al. Factor structure and concurrent validity of the Satisfaction with Life Domains Scale for cancer (SLDS-C). J Psychosoc Oncol. 2007; 25(2):1–17.
24. Hong SH, Park EH, Hong HY. Estimating adolescent's hanges in self-concept Tests of the effects of parents and peers on individual differences in the changes. Stud Korean Youth. 2006; 17(2):241–263.
25. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: A theoretical model. Soc Sci Med. 1999; 48(11):1507–1515.
26. Bevans M. Health-related quality of life following allogeneic hematopoietic stem cell transplantation. Hematology Am Soc Hematol Educ Program. 2010; 2010:248–254. DOI:
10.1182/asheducation-2010.1.248.
27. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004; 291(19):2335–2343. DOI:
10.1001/jama.291.19.2335.
28. Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, et al. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005; 35(1):77–83. DOI:
10.1038/sj.bmt.1704709.
29. Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L. A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant. 2009; 43(9):725–737. DOI:
10.1038/bmt.2009.27.
30. Grulke N, Albani C, Bailer H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire QLQ-C30. Bone Marrow Transplantation. 2012; 47(4):473–482. DOI:
10.1038/bmt.2011.107.